<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[My Site]]></title><description><![CDATA[My Site]]></description><link>https://www.glial-pathology-lab.com/blog</link><generator>RSS for Node</generator><lastBuildDate>Wed, 03 Jun 2026 14:09:28 GMT</lastBuildDate><atom:link href="https://www.glial-pathology-lab.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Welcoming Dr. Sebastian Quintremil]]></title><description><![CDATA[Dr. Sebastian Quintremil joined the Glial Pathology lab in November of 2025 for his expertise in cell biology and Alzheimer's disease models. Dr. Quintremil's work will be crucial to advance our understanding of the role of CD44 in Alzheimer's disease, particularly in astrocytes. Welcome.]]></description><link>https://www.glial-pathology-lab.com/post/welcoming-dr-sebastian-quintremil</link><guid isPermaLink="false">69f6b15e90b4365cb8644366</guid><pubDate>Sun, 03 May 2026 02:22:23 GMT</pubDate><dc:creator>Osama Al Dalahmah</dc:creator></item><item><title><![CDATA[Welcome Dr. Qing (Vivian) Zhou]]></title><description><![CDATA[Dr. Zhou received her Ph.D. in Pharmacology from Tsinghua University and her M.S. in Biostatistics from Columbia University. Her research focuses on developing novel therapeutic strategies for cancer, with a particular emphasis on glioblastoma. Her work centers on targeting cancer-related transcriptional programs. She has extensive experience in designing and evaluating approaches to modulate transcription factor activity, and in assessing their efficacy across multiple cancer models,...]]></description><link>https://www.glial-pathology-lab.com/post/welcome-dr-qing-vivian-zhou</link><guid isPermaLink="false">69f6a20a90b4365cb86421de</guid><pubDate>Sun, 03 May 2026 01:20:11 GMT</pubDate><dc:creator>Osama Al Dalahmah</dc:creator></item></channel></rss>